M

Mereo BioPharma Group plc (MREO)

NCM – Real Time Price. Currency in USD

0.29

-0.01 (-4.58%)

Market open: Aug 12, 2026, 11:25 AM EDT

0.31

+0.00 (1.34%)

Previous after-hours: Aug 11, 2026, 7:59 PM EDT

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Mereo BioPharma Group plc (MREO)

NCM – Real Time Price. Currency in USD

0.29

-0.01 (-4.58%)

Market open: Aug 12, 2026, 11:25 AM EDT

0.31

+0.00 (1.34%)

Previous after-hours: Aug 11, 2026, 7:59 PM EDT

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

501K

0

10M

0

Cost of goods sold

-1M

-4M

257K

Gross Profit

-784K

-1M

6M

257K

Operating expenses (excl. COGS)

-40M

-46M

-35M

-54M

Operating Income

-41M

-47M

-29M

-54M

Non-operating income, total

-3M

2M

-3M

9M

Pretax income

-44M

-45M

-31M

-44M

Equity in earnings

0

Taxes

2M

Non-controlling/minority interest

0

After tax other income/expense

0

Net income before discontinued operations

-42M

-43M

-30M

-42M

Discontinued operations

0

Net income

-42M

-43M

-30M

-42M

Dilution adjustment

0

Preferred dividends

0

Search stocks

Mereo BioPharma Group plc (MREO)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Mereo BioPharma Group plc (MREO)

Income Statement (Annual)